Renal cell carcinoma CT: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(18 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Renal cell carcinoma}}
{{Renal cell carcinoma}}
{{CMG}}
{{CMG}} {{AE}} {{F.K}} {{Rim}}


==Overview==
==Overview==
a CT may be used to detect neoplastic masses that may define renal cell carcinoma or metastasis of the primary cancer.
Renal CT scan may be helpful in the diagnosis of renal cell carcinoma. CT may be used to detect [[neoplastic]] masses that may define renal cell carcinoma or [[metastasis]] of primary cancer.
 
 
==Computed Tomography==
==Computed Tomography==
Both CT and MRI may be used to detect neoplastic masses that may define renal cell carcinoma or metastasis of the primary cancer. CT scan and use of intravenous (IV) contrast is generally used for work-up and follow-up of patients with renal cell carcinoma. Enhancing renal masses on CT scan is strongly indicative of the presence of a renal tumor.<ref name="pmid16339096‎">{{cite journal| author=Cohen HT, McGovern FJ| title=Renal-cell carcinoma. | journal=N Engl J Med | year= 2005 | volume= 353 | issue= 23 | pages= 2477-90 | pmid=16339096‎ | doi=10.1056/NEJMra043172 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16339096  }} </ref> <br> It is always important to note the significance of radiation exposure in the recurrent use of CT scan for surveillance.
Renal CT scan may be helpful in the diagnosis of renal cell carcinoma. CT may be used to detect [[neoplastic]] masses that may define renal cell carcinoma or [[metastasis]] of the primary cancer. CT scan and use of intravenous (IV) [[contrast]] is generally used for work-up and follow-up of patients with renal cell carcinoma.<ref name="pmid16339096‎">{{cite journal| author=Cohen HT, McGovern FJ| title=Renal-cell carcinoma. | journal=N Engl J Med | year= 2005 | volume= 353 | issue= 23 | pages= 2477-90 | pmid=16339096‎ | doi=10.1056/NEJMra043172 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16339096  }} </ref> <ref name="pmid20479778">{{cite journal |vauthors=Leveridge MJ, Bostrom PJ, Koulouris G, Finelli A, Lawrentschuk N |title=Imaging renal cell carcinoma with ultrasonography, CT and MRI |journal=Nat Rev Urol |volume=7 |issue=6 |pages=311–25 |date=June 2010 |pmid=20479778 |doi=10.1038/nrurol.2010.63 |url=}}</ref><br> The following guidelines of the American Urological Association in 2013 state the following regarding the use of CT in renal cell carcinoma:
<br> The following guidelines of the American Urological Association in 2013 state the following regarding the use of CT in renal cell carcinoma:
<br>
<br>
{|border="1" style="border-collapse:collapse; text-align:left;" cellpadding="5" align="center"
{|
|+ '''''Use of CT in Renal Cell Carcinoma<ref name="pmid23665399">{{cite journal| author=Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH et al.| title=Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline. | journal=J Urol | year= 2013 | volume= 190 | issue= 2 | pages= 407-16 | pmid=23665399 | doi=10.1016/j.juro.2013.04.121 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23665399  }} </ref>'''''
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |'''''Use of CT in Renal Cell Carcinoma<ref name="pmid23665399">{{cite journal| author=Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH et al.| title=Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline. | journal=J Urol | year= 2013 | volume= 190 | issue= 2 | pages= 407-16 | pmid=23665399 | doi=10.1016/j.juro.2013.04.121 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23665399  }} </ref>'''''
| bgcolor="#d9ff54"|'''Patient Profile''' || bgcolor="#d9ff54"|'''Use of CT'''|| bgcolor="#d9ff54"|'''Evidence Strength'''
|-
|-
| bgcolor="#ececec"|'''Low Risk Patient (pT1, N0, Nx)''' ||Baseline abdominal CT (or MRI) for nephron sparing surgery and CT (or US or MRI) for radical nephrectomy within 3-12 months following renal surgery <br><br>Additional CT (or US or MRI) may be performed in patients following radical nephrectomy if initial post-op baseline image is negative||Expert opinion <br><br>C
! style="background:#7d7d7d; color: #FFFFFF;" align="center" + |'''Patient Profile'''
! style="background:#7d7d7d; color: #FFFFFF;" align="center" + |'''Use of CT'''
! style="background:#7d7d7d; color: #FFFFFF;" align="center" + |'''Evidence Strength''
|-
|-
| bgcolor="#ececec"|'''Moderate to High Risk Patients (pT2-4N0 Nx or any stage N+)''' ||Baseline chest and abdominal CT (or MRI) within 3-6 months following surgery with continued imaging (US, CXR, CT, or MRI) every 6 months for at least 3 years and annually thereafter to 5 years. Site specific imaging is warranted by clinical symptoms suggestive of recurrence or metastatic spread. Imaging (US, CXR, CT, or MRI) beyond 5 years may be performed at the discretion of the clinician|| C
| style="background:#DCDCDC;" + |'''Low Risk Patient (pT1, N0, Nx)'''  
| style="background:#F5F5F5;" + |Baseline abdominal CT (or MRI) for nephron sparing surgery and CT (or US or MRI) for radical nephrectomy within 3-12 months following renal surgery <br><br>Additional CT (or US or MRI) may be performed in patients following radical nephrectomy if initial post-op baseline image is negative
| style="background:#F5F5F5;" align="center" + |Expert opinion<br>C
|-
|-
| bgcolor="#ececec"|'''Active surveillance''' || Cross-sectional abdominal scanning (CT or MRI) within 6 months of active surveillance initiation to establish a growth rate. Further imaging is recommended at least annually thereafter|| C
| style="background:#DCDCDC;" + |'''Moderate to High Risk Patients (pT2-4N0 Nx or any stage N+)'''  
| style="background:#F5F5F5;" + |Baseline chest and abdominal CT (or MRI) within 3-6 months following surgery with continued imaging (US, CXR, CT, or MRI) every 6 months for at least 3 years and annually thereafter to 5 years. Site specific imaging is warranted by clinical symptoms suggestive of recurrence or metastatic spread. Imaging (US, CXR, CT, or MRI) beyond 5 years may be performed at the discretion of the clinician
| style="background:#F5F5F5;" align="center" + |C
|-
|-
| bgcolor="#ececec"|'''Ablation ''' || Patients undergo cross-sectional CT or MRI with and without IV contrast unless contraindicated at 3 and 6 months following ablative therapy to assess treatment success. Annual abdominal CT or MRI should follow for 5 years. Individual CT (or MRI) beyond 5 years is based on individual patient risk factors || C
| style="background:#DCDCDC;" + |'''Active surveillance'''
| style="background:#F5F5F5;" + |Cross-sectional abdominal scanning (CT or MRI) within 6 months of active surveillance initiation to establish a growth rate. Further imaging is recommended at least annually thereafter
| style="background:#F5F5F5;" align="center" + |C
|-
| style="background:#DCDCDC;" + |'''Ablation '''  
| style="background:#F5F5F5;" + |Patients undergo cross-sectional CT or MRI with and without IV contrast unless contraindicated at 3 and 6 months following ablative therapy to assess treatment success. Annual abdominal CT or MRI should follow for 5 years. Individual CT (or MRI) beyond 5 years is based on individual patient risk factors  
| style="background:#F5F5F5;" align="center" + | C
|}
|}


<sup><center>Adapted from Donat SM et al. Follow-up for clinically localized renal neoplasms: AUA guideline. ''J Urol''. 2013; 190(2):407-16. </center></sup>
<sup><center>Adapted from Donat SM et al. Follow-up for clinically localized renal neoplasms: AUA guideline. ''J Urol''. 2013; 190(2):407-16. </center>
===Patient 1===
[http://www.radswiki.net Images courtesy of RadsWiki]
<gallery mode="nolines" heights=300px widths=300px>
Image:Renal cell carcinoma with intravascular extension 001.jpg|
Image:Renal cell carcinoma with intravascular extension 002.jpg|
Image:Renal cell carcinoma with intravascular extension 003.jpg|
Image:Renal cell carcinoma with intravascular extension 004.jpg|
Image:Renal cell carcinoma with intravascular extension 005.jpg|
</gallery>


===Patient 2===
[[File:Hypovascular-renal-cell-carcinoma.jpg|300px|thumb|left|CT scan showing renal cell carcinoma [https://radiopaedia.org/cases/hypovascular-renal-cell-carcinoma source:Case courtesy of Dr Roberto Schubert, Radiopaedia.org, rID: 16088]]]
[http://www.radswiki.net Images courtesy of RadsWiki]
<br style="clear:left" />
<gallery mode="nolines" heights=300px widths=300px>
Image:Large renal cell carcinoma 001.jpg|
Image:Large renal cell carcinoma 002.jpg|
Image:Large renal cell carcinoma 003.jpg|
</gallery>


===Patient 3===
[[File:Transitional-cell-carcinoma-of-the-renal-pelvis.jpg|300px|thumb|left|CT scan showing renal cell carcinoma [https://radiopaedia.org/cases/https://radiopaedia.org/cases/transitional-cell-carcinoma-of-the-renal-pelvis source:Case courtesy of Dr Roberto Schubert, Radiopaedia.org, rID: 14163]]]
[http://www.radswiki.net Images courtesy of RadsWiki]
<br style="clear:left" />
<gallery mode="nolines" heights=300px widths=300px>
Image:Renal-cell-carcinoma-003.jpg|
Image:Renal-cell-carcinoma-004.jpg|
Image:Renal-cell-carcinoma-001.jpg|
Image:Renal-cell-carcinoma-002.jpg|
</gallery>
 
===Patient 4===
[http://www.radswiki.net Images courtesy of RadsWiki]
<gallery mode="nolines" heights=300px widths=300px>
Image:Renal cell carcinoma 001.jpg|
Image:Renal cell carcinoma 002.jpg|
Image:Renal cell carcinoma 003.jpg|
Image:Renal cell carcinoma 004.jpg|
Image:Renal cell carcinoma 005.jpg|
Image:RCC.jpg|
</gallery>


==References==
==References==
Line 70: Line 47:
[[Category:Nephrology]]
[[Category:Nephrology]]
[[Category:Mature chapter]]
[[Category:Mature chapter]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Nephrology]]
[[Category:Surgery]]

Latest revision as of 16:47, 11 December 2018

Renal cell carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Renal cell carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Renal cell carcinoma CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Renal cell carcinoma CT

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Renal cell carcinoma CT

CDC on Renal cell carcinoma CT

Renal cell carcinoma CT in the news

Blogs on Renal cell carcinoma CT

Directions to Hospitals Treating Renal cell carcinoma

Risk calculators and risk factors for Renal cell carcinoma CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farima Kahe M.D. [2] Rim Halaby, M.D. [3]

Overview

Renal CT scan may be helpful in the diagnosis of renal cell carcinoma. CT may be used to detect neoplastic masses that may define renal cell carcinoma or metastasis of primary cancer.

Computed Tomography

Renal CT scan may be helpful in the diagnosis of renal cell carcinoma. CT may be used to detect neoplastic masses that may define renal cell carcinoma or metastasis of the primary cancer. CT scan and use of intravenous (IV) contrast is generally used for work-up and follow-up of patients with renal cell carcinoma.[1] [2]
The following guidelines of the American Urological Association in 2013 state the following regarding the use of CT in renal cell carcinoma:

Use of CT in Renal Cell Carcinoma[3]
Patient Profile Use of CT 'Evidence Strength
Low Risk Patient (pT1, N0, Nx) Baseline abdominal CT (or MRI) for nephron sparing surgery and CT (or US or MRI) for radical nephrectomy within 3-12 months following renal surgery

Additional CT (or US or MRI) may be performed in patients following radical nephrectomy if initial post-op baseline image is negative
Expert opinion
C
Moderate to High Risk Patients (pT2-4N0 Nx or any stage N+) Baseline chest and abdominal CT (or MRI) within 3-6 months following surgery with continued imaging (US, CXR, CT, or MRI) every 6 months for at least 3 years and annually thereafter to 5 years. Site specific imaging is warranted by clinical symptoms suggestive of recurrence or metastatic spread. Imaging (US, CXR, CT, or MRI) beyond 5 years may be performed at the discretion of the clinician C
Active surveillance Cross-sectional abdominal scanning (CT or MRI) within 6 months of active surveillance initiation to establish a growth rate. Further imaging is recommended at least annually thereafter C
Ablation Patients undergo cross-sectional CT or MRI with and without IV contrast unless contraindicated at 3 and 6 months following ablative therapy to assess treatment success. Annual abdominal CT or MRI should follow for 5 years. Individual CT (or MRI) beyond 5 years is based on individual patient risk factors C
Adapted from Donat SM et al. Follow-up for clinically localized renal neoplasms: AUA guideline. J Urol. 2013; 190(2):407-16.
CT scan showing renal cell carcinoma source:Case courtesy of Dr Roberto Schubert, Radiopaedia.org, rID: 16088


CT scan showing renal cell carcinoma source:Case courtesy of Dr Roberto Schubert, Radiopaedia.org, rID: 14163


References

  1. Cohen HT, McGovern FJ (2005). "Renal-cell carcinoma". N Engl J Med. 353 (23): 2477–90. doi:10.1056/NEJMra043172. PMID 16339096‎ Check |pmid= value (help).
  2. Leveridge MJ, Bostrom PJ, Koulouris G, Finelli A, Lawrentschuk N (June 2010). "Imaging renal cell carcinoma with ultrasonography, CT and MRI". Nat Rev Urol. 7 (6): 311–25. doi:10.1038/nrurol.2010.63. PMID 20479778.
  3. Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH; et al. (2013). "Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline". J Urol. 190 (2): 407–16. doi:10.1016/j.juro.2013.04.121. PMID 23665399.